Abbott SCSPENDING
Nevro SCSPENDING
Cyclosporiasis OutbreakPENDING
Dupixent CTCLNEW MDL
Boston Sci. SCSNEW MDL
AI Chatbot Harm
NEWMONITOR
Roundup
ACTIVE
AFFF
ACTIVE
Depo-Provera
QUIET
Talc
QUIET
PFAS
ACTIVE
NEC Formula
ACTIVE
Bard Hernia Mesh
QUIET
Covidien Hernia Mesh
ACTIVE
Camp Lejeune
ACTIVE
Paraquat
ACTIVE
Social Media
ACTIVE
PowerPort
ACTIVE
AngioDynamics Port
ACTIVE
EtO Sterilization
ACTIVE
Hair Relaxer
ACTIVE
Paragard
ACTIVE
Suboxone Teeth
ACTIVE
Uber Assault
ACTIVE
Lyft Assault
ACTIVE
Ozempic Gastroparesis
ACTIVE
Ozempic NAION
MONITOR
Church Abuse
ACTIVE
1,4-Dioxane
MONITOR
Hotel Trafficking
ACTIVE
Boy Scouts
QUIET
LDS Abuse
ACTIVE
Keytruda
ACTIVE
Tylenol
ACTIVE
Assembly of God
ACTIVE
Video Game Addiction
ACTIVE
CA Women's Prisons
ACTIVE
Zantac
ACTIVE
ByHeart Formula
MONITOR
Cartiva
MONITOR
Roblox
ACTIVE
Sports Betting
MONITOR
Baby Food Metals
QUIET
Benzene Litigation
ACTIVE
Discord Abuse
ACTIVE
Social Media Sextortion
MONITOR
UPF Litigation
MONITOR
47Tracked
28Active
3Pending
Navigation
Abbott SCSPENDING
Nevro SCSPENDING
Cyclosporiasis OutbreakPENDING
Dupixent CTCLNEW MDL
Boston Sci. SCSNEW MDL
AI Chatbot Harm
NEWMONITOR
Roundup
ACTIVE
AFFF
ACTIVE
Depo-Provera
QUIET
Talc
QUIET
PFAS
ACTIVE
NEC Formula
ACTIVE
Bard Hernia Mesh
QUIET
Covidien Hernia Mesh
ACTIVE
Camp Lejeune
ACTIVE
Paraquat
ACTIVE
Social Media
ACTIVE
PowerPort
ACTIVE
AngioDynamics Port
ACTIVE
EtO Sterilization
ACTIVE
Hair Relaxer
ACTIVE
Paragard
ACTIVE
Suboxone Teeth
ACTIVE
Uber Assault
ACTIVE
Lyft Assault
ACTIVE
Ozempic Gastroparesis
ACTIVE
Ozempic NAION
MONITOR
Church Abuse
ACTIVE
1,4-Dioxane
MONITOR
Hotel Trafficking
ACTIVE
Boy Scouts
QUIET
LDS Abuse
ACTIVE
Keytruda
ACTIVE
Tylenol
ACTIVE
Assembly of God
ACTIVE
Video Game Addiction
ACTIVE
CA Women's Prisons
ACTIVE
Zantac
ACTIVE
ByHeart Formula
MONITOR
Cartiva
MONITOR
Roblox
ACTIVE
Sports Betting
MONITOR
Baby Food Metals
QUIET
Benzene Litigation
ACTIVE
Discord Abuse
ACTIVE
Social Media Sextortion
MONITOR
UPF Litigation
MONITOR
47Tracked
28Active
3Pending
LexGenius Logo
LexGeniusYour Edge in Mass Litigation
PricingDaily DocketTrack litigations freeSign in
LexGenius

LexGenius

Your Edge in Mass Litigation

DisclaimerAcceptable UseTermsPrivacyCookie PolicySupport

© 2026 LexGenius. All rights reserved.

← All Briefs

Daily Intelligence Brief

Monday, August 10, 2026

Suboxone Spike Concentrates a 555-Filing Week

Mass-tort intake concentrated sharply as Suboxone Film Products Liability (3092) produced 160 filings, with Nigh Goldenberg Raso Vaughn PLLC leading the listed filer roster with two and Peiffer Wolf adding one. Aqueous Film-Forming Foams Personal Injury Products Liability (2873) added 91 filings through Krentsel & Guzman LLP’s 40 and Keefe Law Firm LLC’s 20, preserving PFAS as the week’s largest nonpharma channel. Hair Relaxer Marketing, Sales Practices, and Products Liability (3060) logged 68 filings, led by Wallace Miller’s 12 and Morgan & Morgan PA’s 10, while Social Media Adolescent Addiction Personal Injury Products Liability (3047) drew 52 through nine filings each from Levin Papantonio and Weitz & Luxenberg PC. Zantac Products Liability (2924) added 36 filings, all from Keller Postman LLC, reflecting continuing tag-along activity rather than a federal merits revival. See the full filing feed and firm-level breakdowns here.

Colorado Sets an August 12 Betting-Controls Deadline

Colorado’s sports-betting protections take effect August 12, barring operators from accepting credit-card-funded deposits and limiting each bettor to six deposits in a gaming day. The statute moves compliance from general responsible-gaming messaging to transaction-level controls, creating a concrete benchmark for addiction-related claims against operators. An operator that accepts prohibited credit-card funding faces up to $25,000 in regulatory penalties per violation. The rules’ imminent launch will sharpen disputes over whether operators’ safeguards matched recognized risk controls when harm allegedly occurred.

Hair Relaxer Bellwether Expert Fight Turns to Rebuttal

Plaintiffs in Hair Relaxer Marketing, Sales Practices, and Products Liability (3060) face an August 17 expert-rebuttal deadline in the initial bellwether cases, putting their response to defense experts on the immediate litigation clock. The court’s schedule requires case-specific and other non-general-causation rebuttal reports, making this the final expert-disclosure turn before case-specific discovery closes. Those reports will define which differential-causation and damages theories enter the deposition phase on a record capable of surviving motion practice. The deadline therefore tightens bellwether leverage by forcing both sides to expose the individualized proof they will carry into the next merits stage.

Generated by LexGenius Feed. Signals sourced from PACER federal court dockets, FDA/OpenFDA adverse event database, Federal Register, PubMed, and Google News.